Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors
- PMID: 26341371
- DOI: 10.1007/s11060-015-1906-y
Prognostic significance of relative 1p/19q codeletion in oligodendroglial tumors
Abstract
1p/19q codeletion is a favorable prognostic marker for oligodendroglial tumors (OT). Compare outcome in OT with simple deletions of 1p or 19q to those with relative deletions defined as the presence of both increased copy number (polysomy) and 1p/19q codeletion. 525 cases were examined by fluorescence in situ hybridization (FISH) using dual color probes to determine the deletion status of chromosome arms 1p and 19q. Categories included simple deletions defined as a proportion of either 1p32 or 19q13 FISH signals compared to 1q42 or 19p13 signals less than 0.80 and relative deletions (1p or 19q) defined as the combination of a <0.80 proportion with >30 % of nuclei showing increased chromosome number (based on enumeration of 1q25 or 19p13). 464 (80 %) were WHO Grade II or III OT of which 209 (48 %) had both 1p and 19q deleted (codeletion). 72 (16 %) had relative deletions for either one or both 1p and 19q of which 28 (6 %) had relative deletions of 1p and 19q (relative codeletion). Overall survival in WHO Grade II OT was 13 + years when 1p/19q codeleted (n = 156); 5 + years in uni- or nondeleted (n = 86); 6 + years in relative deletion for either 1p or 19q (n = 41); and 6 + years in relative 1p/19q codeletion (n = 15). Similarly in WHO Grade III OT (n = 168) overall survival was 11 + years in 1p/19q codeleted (n = 54) OT; 2.5 years in uni- or nondeleted (n = 70); 3 years in relative deletion for one or both 1p or 19q (n = 31); and 4 + years in relative 1p/19q codeletion (n = 13). Survival for OT regardless of grade with relative codeletion of 1p/19q was approximately one half that of 1p/19q codeleted tumors. The presence of relative 1p/19q codeletion is of prognostic significance.
Keywords: Oligodendroglioma; Polysomy; Relative1p/19q codeletion.
Similar articles
-
Application of brush cytology for FISH-based detection of 1p/19q codeletion in oligodendroglial tumors.J Neurooncol. 2016 Sep;129(3):415-422. doi: 10.1007/s11060-016-2211-0. Epub 2016 Jul 12. J Neurooncol. 2016. PMID: 27406587
-
Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms.Neurol India. 2014 Jan-Feb;62(1):32-6. doi: 10.4103/0028-3886.128275. Neurol India. 2014. PMID: 24608451
-
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumors.Neuro Oncol. 2019 Sep 6;21(9):1164-1174. doi: 10.1093/neuonc/noz098. Neuro Oncol. 2019. PMID: 31140557 Free PMC article.
-
[Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice].Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):595-604. doi: 10.1016/j.neurol.2008.04.002. Epub 2008 May 21. Rev Neurol (Paris). 2008. PMID: 18565359 Review. French.
-
Diagnostic accuracy of 1p/19q codeletion tests in oligodendroglioma: A comprehensive meta-analysis based on a Cochrane systematic review.Neuropathol Appl Neurobiol. 2022 Jun;48(4):e12790. doi: 10.1111/nan.12790. Epub 2022 Mar 3. Neuropathol Appl Neurobiol. 2022. PMID: 34958131 Free PMC article.
Cited by
-
Chromosomal Aberrations in Canine Gliomas Define Candidate Genes and Common Pathways in Dogs and Humans.J Neuropathol Exp Neurol. 2016 Jul;75(7):700-10. doi: 10.1093/jnen/nlw042. Epub 2016 May 31. J Neuropathol Exp Neurol. 2016. PMID: 27251041 Free PMC article.
-
MRI radiomics analysis of molecular alterations in low-grade gliomas.Int J Comput Assist Radiol Surg. 2018 Apr;13(4):563-571. doi: 10.1007/s11548-017-1691-5. Epub 2017 Dec 21. Int J Comput Assist Radiol Surg. 2018. PMID: 29270916
-
1p and/or 19q polysomy is an adverse prognostic factor in oligodendrogliomas, and easy to detect by automated FISH.PLoS One. 2025 May 2;20(5):e0322809. doi: 10.1371/journal.pone.0322809. eCollection 2025. PLoS One. 2025. PMID: 40315229 Free PMC article.
-
Applications of radiomics and machine learning for radiotherapy of malignant brain tumors.Strahlenther Onkol. 2020 Oct;196(10):856-867. doi: 10.1007/s00066-020-01626-8. Epub 2020 May 11. Strahlenther Onkol. 2020. PMID: 32394100 Free PMC article. Review.
-
Recent advances and future of immunotherapy for glioblastoma.Expert Opin Biol Ther. 2016 Oct;16(10):1245-64. doi: 10.1080/14712598.2016.1212012. Epub 2016 Jul 27. Expert Opin Biol Ther. 2016. PMID: 27411023 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical